Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.

Feb 1, 1994Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research

Long-term phorbol ester treatment changes protein kinase C activity, amount, and gene expression in human immune-like U937 cells

AI simplified

Abstract

Sustained activation of protein kinase C (PKC) is essential for phorbol ester-induced differentiation of U937 cells into monocyte/macrophage-like cells.

  • Chronic activation of the PKC pathway alters the signal transduction profile compared to initial phorbol ester application.
  • AP-1 binding activity increased in response to 12-O-tetradecanoylphorbol-13-acetate (TPA), showing a temporal dependency with a notable shift after 12 hours.
  • Maximal enhancement of AP-1 binding activity occurred with 1 nM TPA after 72 hours, remaining elevated despite higher concentrations.
  • Sustained TPA exposure was crucial for enhanced AP-1 binding activity, which was not a result of cellular differentiation.
  • A 72-hour treatment with 1 nM TPA significantly boosted the expression of c-jun, krox-24, and jun-B mRNA transcripts, while higher concentrations reduced their levels.
  • Higher TPA concentrations (100 nM) were required for maximal expression of collagenase and plasminogen activator receptor transcripts.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free